Back to results

CompletedPhase 3

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

NCT00675623

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix, Arizona, United States

+27 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-05
Enrollment: 598 participants
Sponsor: Medivation, Inc.
Purpose: treatment

Locations (28)

Phoenix, Arizona, United States
Costa Mesa, California, United States
Fresno, California, United States
Rancho Mirage, California, United States
Hamden, Connecticut, United States
New Haven, Connecticut, United States
Norwalk, Connecticut, United States
Hallandale, Florida, United States
Hialeah, Florida, United States
Miami, Florida, United States
North Miami, Florida, United States
Sunrise, Florida, United States
West Palm Beach, Florida, United States
Indianapolis, Indiana, United States
Paducah, Kentucky, United States
Newton, Massachusetts, United States
Ann Arbor, Michigan, United States
St Louis, Missouri, United States
Brooklyn, New York, United States
Cedarhurst, New York, United States
New York, New York, United States
Rochester, New York, United States
Staten Island, New York, United States
Morganton, North Carolina, United States
Centerville, Ohio, United States
Norristown, Pennsylvania, United States
Austin, Texas, United States
Middleton, Wisconsin, United States

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease — TrialFind